Cochlear Future Growth

Future criteria checks 2/6

Cochlear is forecast to grow earnings and revenue by 11.7% and 8.1% per annum respectively. EPS is expected to grow by 11.7% per annum. Return on equity is forecast to be 25% in 3 years.

Key information

11.7%

Earnings growth rate

11.7%

EPS growth rate

Medical Equipment earnings growth17.1%
Revenue growth rate8.1%
Future return on equity25.0%
Analyst coverage

Good

Last updated20 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

OTCPK:CHEO.Y - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20272,92153148660013
6/30/20262,67646740952114
6/30/20252,46342240852214
6/30/20242,236357299389N/A
3/31/20242,193354317410N/A
12/31/20232,149350335430N/A
9/30/20232,043326301396N/A
6/30/20231,936301267362N/A
3/31/20231,824281263352N/A
12/31/20221,713261259341N/A
9/30/20221,681275279359N/A
6/30/20221,648289299377N/A
3/31/20221,612273266340N/A
12/31/20211,575257233304N/A
9/30/20211,536291216285N/A
6/30/20211,498324199265N/A
3/31/20211,40382-5234N/A
12/31/20201,308-160-302-198N/A
9/30/20201,314-199-295-178N/A
6/30/20201,321-238-288-158N/A
3/31/20201,40034-8050N/A
12/31/20191,479306128259N/A
9/30/20191,453291155277N/A
6/30/20191,427277181296N/A
3/31/20191,422270217313N/A
12/31/20181,418264252330N/A
9/30/20181,391255230294N/A
6/30/20181,364246208258N/A
3/31/20181,329234N/A254N/A
12/31/20171,294223N/A250N/A
9/30/20171,274223N/A255N/A
6/30/20171,254224N/A260N/A
3/31/20171,218215N/A237N/A
12/31/20161,182206N/A214N/A
9/30/20161,156198N/A199N/A
6/30/20161,131189N/A185N/A
3/31/20161,088179N/A179N/A
12/31/20151,045168N/A172N/A
9/30/2015986157N/A181N/A
6/30/2015926146N/A189N/A
3/31/2015899145N/A178N/A
12/31/2014872144N/A168N/A
9/30/2014839119N/A140N/A
6/30/201480594N/A111N/A
3/31/201476985N/A93N/A
12/31/201373276N/A75N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CHEO.Y's forecast earnings growth (11.7% per year) is above the savings rate (2.6%).

Earnings vs Market: CHEO.Y's earnings (11.7% per year) are forecast to grow slower than the US market (15.3% per year).

High Growth Earnings: CHEO.Y's earnings are forecast to grow, but not significantly.

Revenue vs Market: CHEO.Y's revenue (8.1% per year) is forecast to grow slower than the US market (8.9% per year).

High Growth Revenue: CHEO.Y's revenue (8.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CHEO.Y's Return on Equity is forecast to be high in 3 years time (25%)


Discover growth companies